- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Opko Health Inc (OPK)
Opko Health Inc stock price live, this page displays NASDAQ OPK stock exchange data. View the OPK premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Opko Health Inc real time stock price chart below.
What Is the Opko Health Inc Stock Price Today?
The Opko Health Inc stock price today is 1.480.
What Is the Stock Symbol for Opko Health Inc?
The stock symbol for Opko Health Inc is "OPK."
What Stock Exchange Does Opko Health Inc Trade On?
Opko Health Inc is listed and trades on the NASDAQ stock exchange.
Is Opko Health Inc a Good Stock to Buy?
Determining whether Opko Health Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the OPK quote. (ISIN: US68375N1037)
What Is the Opko Health Inc Stock Price Today?
The Opko Health Inc stock price today is 1.480.
What Is the Stock Symbol for Opko Health Inc?
The stock symbol for Opko Health Inc is "OPK."
What Stock Exchange Does Opko Health Inc Trade On?
Opko Health Inc is listed and trades on the NASDAQ stock exchange.
Is Opko Health Inc a Good Stock to Buy?
Determining whether Opko Health Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the OPK quote. (ISIN: US68375N1037)
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.455
1.520
52 wk Range
0.977
1.730
OPK is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.4551.520
52 wk Range
0.9771.730
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
OPK Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
4.375
Upside
+195.61%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts do not anticipate the company will be profitable this year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Analyst Ratings
4 Buy
2 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 4.375
(+195.61% Upside)
Opko Health Inc Earnings Call Summary for Q2/2026
- OPKO Health reported Q2 2026 loss of $0.01/share, beating analyst estimates of $0.08/share by 87.5%; shares rose 2.46% in regular trading, up 7.26% after-hours.
- Revenue increased 4.4% to $163.6M; operating loss narrowed to $7M from $60M year-over-year as BioReference diagnostics returned to profitability post-restructuring.
- Company raised full-year 2026 revenue guidance to $560M-$585M and lowered cost outlook to $710M-$740M, excluding one-time items.
- Q3 2026 guidance: revenue of $131M-$142M, total costs $180M-$190M; diagnostics targeting breakeven as 4Kscore expansion delayed pending Medicare decisions.
- OPKO repurchased 9.7M shares for $13M in Q2; maintains $300M+ cash position to fund five clinical ModeX programs and sixth trial expected by year-end 2026.
Last Updated: 2026-07-27, 05:38 p/m
Read Full TranscriptEarnings
Latest Release
Jul 27, 2026
EPS / Forecast
-0.01 / -0.08
Revenue / Forecast
163.5M / 131.03M
Compare OPK to Peers and Sector
Metrics to compare | OPK | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipOPKPeersSector | |
|---|---|---|---|---|
P/E Ratio | −15.2x | −6.5x | −0.4x | |
PEG Ratio | −0.24 | 0.56 | 0.00 | |
Price/Book | 0.9x | 2.0x | 2.6x | |
Price / LTM Sales | 1.9x | 2.2x | 3.1x | |
Upside (Analyst Target) | 102.7% | 23.9% | 48.9% | |
Fair Value Upside | Unlock | 17.2% | 6.2% | Unlock |
OPKO Health, Inc. operates as a healthcare company, in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company operates in two segments, Pharmaceutical and Diagnostics. The Pharmaceutical segment develops MDX2001, a tetra-specific antibody targeting several types of solid tumors in Phase 1 clinical trials; MDX2003, a tetra-specific antibody targeting two antigens for hematological tumors in Phase 1 clinical trials; and MDX2004, a trispecific immune modulator to rebuild and sustain the patient's own immune system. This segment also engages in the development of Epstein Barr Virus vaccine; Rayaldee, a patented extended-release product for oral administration containing 30 mcg of a prohormone; OPK-88006 oral and injectable product to regulate blood glucose and reduce body weight; NGENLA, recombinant human growth hormone product developed for the long-term treatment of pediatric patients with growth hormone deficiency. The Diagnostics segment offers laboratory testing services, such as detection, diagnosis, evaluation, monitoring, and treatment of diseases, as well as esoteric testing, molecular diagnostics, anatomical pathology, genetics, women’s health, and correctional healthcare under the BioReference brand; and 4Kscore test. OPKO Health, Inc. was founded in 2006 and is headquartered in Miami, Florida.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Opko Health (OPK) Stock Price Today?
The Opko Health stock price today is 1.480 USD.
What Stock Exchange Does Opko Health Trade On?
Opko Health is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Opko Health?
The stock symbol for Opko Health is "OPK."
What Is the Opko Health Market Cap?
As of today, Opko Health market cap is 1.100B USD.
What Is Opko Health's Earnings Per Share (TTM)?
The Opko Health EPS (TTM) is -0.094.
When Is the Next Opko Health Earnings Date?
Opko Health will release its next earnings report on Nov 11, 2026.
From a Technical Analysis Perspective, Is OPK a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Opko Health Stock Split?
Opko Health has split 0 times.
How Many Employees Does Opko Health Have?
Opko Health has 2275 employees.
What is the current trading status of Opko Health (OPK)?
As of Aug 23, 2026, Opko Health (OPK) is trading at a price of 1.480 USD, with a previous close of 1.460 USD. The stock has fluctuated within a day range of 1.455 USD to 1.520 USD, while its 52-week range spans from 0.977 USD to 1.730 USD.
What Is Opko Health (OPK) Price Target According to Analysts?
The average 12-month price target for Opko Health is 4.375 USD, with a high estimate of 8.5 USD and a low estimate of 3 USD. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +195.61% Upside potential.
What Is the OPK Premarket Price?
OPK's last pre-market stock price is 1.490 USD. The pre-market share volume is 790.000, and the stock has decreased by 0.030, or 2.050%.
What Is the OPK After Hours Price?
OPK's last after hours stock price is 1.478 USD, the stock has decreased by -0.002, or -0.130%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.